Home/Filings/4/0001493152-20-004195
4//SEC Filing

Jabbour Jerome D 4

Accession 0001493152-20-004195

CIK 0001582554other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 10:50 AM ET

Size

5.2 KB

Accession

0001493152-20-004195

Insider Transaction Report

Form 4
Period: 2020-03-17
Jabbour Jerome D
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2020-03-17$0.65/sh+10,000$6,500799,511 total
Footnotes (1)
  • [F1]The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.64 to $0.65, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Documents

1 file

Issuer

Matinas BioPharma Holdings, Inc.

CIK 0001582554

Entity typeother

Related Parties

1
  • filerCIK 0001698838

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 10:50 AM ET
Size
5.2 KB